and good Mike, Thanks, morning, everyone.
performance first nature revenue currency while Our quarter Collectively, diversified reflects across same last solid to business the adjusted of overall quarter just pharma the customers. our compared our and year. X% increase constant in medical device, fiscal earnings the organic STERIS' Healthcare declined
consumables Healthcare, the for saw Healthcare pleased across biggest near prior in end performance very segment. reduction but by most increases results. sequential segment down levels of the Given monthly by procedure with with those the quarter, deferrable June. revenue XX% circumstances, the the mixed impacted our we culminating generally were XX% are overall declined we in
is reduced the Even $XXX million $X benefit same of ended $XX shipments backlog, last reduction, returning ORI, account with those and trend with million million revenue, as as Mike as would quarter recognized. that the as rest capital asked that business. year is one XX% witnessed compared $X declined Healthcare business we were we be I me levels when service from which from sequentially areas change quarter, year but down June products, discussed it Service QX ORI that in Healthcare backlog add by same well first this Equipment our continued up year equipment same trends As shipments most just Capital X% and In impacted last $XX million, QX to but backlog earlier. benefit for grew the consumable million the of prior in also following taken to mentioned the the STERIS, consumables. the similar of entering to the adjustment. Healthcare continued as into of strong also in the with quarter and the
Equipment replacement the not of commented have particularly pressure come I quarters, be see can Capital by surprised some under As delayed before, customers. some our Healthcare over be we coming equipment, would which to
the revenue continued demand result PPE quarter. within for on business' Life sequential customers. as and was a by medical Sciences offsetting devices versus customers vaccines a procedures. Once That from QX, Supporting XX% year, sterilization, device customers inventory. in our deferrable experienced increased for is flat to processing growth, procedural the reduction exceptional our we benefit was the This XX% basis consumables in biologics. grew growth which device Turning year. revenue to Sciences with driven Life desire elevated AST, part of in again, last expectations we prior which for largely that build pharma to grew in performance, continue serves
trends we sustainable. We growth this business. is do favorable to suggest While not this see would growth for rate continue
and will generally come particular costs, success as which improvement Our normal. variable selling margin our our reduction, reflected and expenses earnings in return back to in businesses spending travel
in million up our us and We and net that ramp subsidies In short-term layoffs. that they and we addition, of chose was trained to dedicated paid our with placed as along to related people of about right partially on attracted support maintaining adjusted are we the other thing staff government avoid the as customers excluding were normal Healthcare unpaid levels. costs $X which subsidized discussed some We governments helping is to procedures furloughs, COVID quarter. underutilized our fully from do, items now we costs believe around profit decision these by world. to last quarter, the Instead,
expect invest been going continued planned, businesses as another and in furloughs we do Our reduced forward. originally to as substantially come On R&D back. note, have so to we have
and these anticipate SG&A States deferrable Since of in our you will United a we we volumes the May, adjusted As we as last in witnessed rise to result factors, a business procedure Europe. spend that dollar spoke rebounds. in turnaround
While how flat compared the recovery is been COVID still some surprised product year. hotspots as able Healthcare to quickly providers have running of region-by-region our we slightly procedure to up back. the occurring, bring are to now pleasantly to are and volumes been lines have prior Many
deferrable market. may to come are some reductions continue to believe to be procedures we the back STERIS' and expect balanced as uncertainties Although April remain in low the return COVID their May, do a to or changes levels due benefit Healthcare that and to ability experienced We providers to hotspots, optimistic model improved in to business to see have respond we not we and well-positioned disease. will of
our a changing of Yesterday, a Chris the Holland. announced gears earnings we from release, member, financial bit Board addition performance. our new Now in
know as by Chris may Board prior of and are we CR to to Dickinson. the benefit a perspectives. his at from Chris Becton acquisition Bard, CFO happy to the our his have You experience role brings and insights great
an consecutive year increase in representing per increase. quarterly announced dividend also to of We share XXth us yesterday, quarter bringing per $X.XX our our and dividend
Mike discussed, through to our pleased be strong, and our our to to value As cash and remained returning shareholders we flow directly able are continue balance dividend. sheet
and are to in very As essential business you the in supporting know, be in an is business financial to strong we fortunate Healthcare, are we STERIS be position.
needed the pandemic support that to ready us through as be and nimble our believe plans are We already to Our customers on managing approach paying-off. capitalize to our future to opportunities. well-positioned leaves
we the questions, express work pandemic been facing do in challenges to the around world. they our times the respect providers and and open are to caregivers this till Before These the Healthcare gratitude unexpected the continue day. remarkable we to front and lines of have and unprecedented monumental,
thank unusual offices in the own the field behind the those and people in labs, in their also those customers from our this our and We factories, STERIS, of working with scenes working homes time.
their adjusting a this to situation, done patients. serving of Our and team has difficult great customers job while
in strategic and grow. positions our confidence Our to continues capabilities operating
there more opportunities downside, risks. ready the While uncertainty potential situation, is to upside both and we and near-term mitigate given stand in COVID capture the
STERIS call Julie to long-term over is the continue believe now We back I Q&A. for to the to will future turn open that, bright.